Volume, Not Price, Fueling Rise in Part D Specialty Derm Drug Spending

Volume, Not Price, Fueling Rise in Part D Specialty Derm Drug Spending

Immunomodulators accounted for 81% of dermatologic drug spending but only made up 3% of prescriptions. Medscape Medical News

For the First Time, CMS Proposes Claims-Based Methods to Identify 340B Drugs Billed to Medicare Part D - 340B Report

In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...] The post For the First Time, CMS Proposes Claims-Based Methods to Identify 340B Drugs Billed to Medicare Part D appeared first on 340B Report.